Malondialdehyde (MDA), a marker of oxidative stress in Beta Thalassemia major patients

Authors

  • Shivaji Mane Lokmanya Tilak Municipal Medical College and Sion Hospital, Mumbai-400022
  • Vibha Sakhare Department of Clinical Biochemistry, Seth Gordhandas Sunderdas Medical College (G.S.M.C.) and King Edward Memorial Hospital (K.E.M.), Parel, Mumbai 400012
  • Neelam Patil Department of Pathology, Topiwala National Medical College & B. Y. L. Nair Charitable Hospital, Dr. A. L. Nair Road, Mumbai – 400008
  • Sachin Patharkar Department of Pathology, Topiwala National Medical College & B. Y. L. Nair Charitable Hospital, Dr. A. L. Nair Road, Mumbai – 400008
  • Megha Bhise Lokmanya Tilak Municipal Medical College and Sion Hospital, Mumbai-400022
  • Dodake Kallappa Dattu Department of Pathology, Topiwala National Medical College & B. Y. L. Nair Charitable Hospital, Dr. A. L. Nair Road, Mumbai – 400008

Keywords:

Beta-thalassemia major, Oxidative stress, Malondialdehyde, Ferritin

Abstract

Background: The severe iron overload in beta thalassemia major patients leads to generation of free radicals and peroxidative tissue injury. This process is characterized by metabolic hyperproduction of reactive oxygen species (ROS) and induced lipid peroxidation (LPO). Malondialdehyde (MDA), a terminal compound of lipid peroxidation, is used widely as an index of oxidative status.

Method: serum MDA, iron, ferritin levels were measured in 49 beta thalassemia patients and were compared with age and gender matched 49 healthy individuals.

Result: The MDA level increased significantly in β thalassemia major patients (3.01±0.38) as compared to controls (1.68±0.2). Serum free iron, serum ferritin level was high in study group.

Conclusion: We conclude that in patients with β thalassemia, MDA is the marker of oxidative stress.

Downloads

Download data is not yet available.

Downloads

Published

2019-12-30

Issue

Section

Original Research Articles

How to Cite

Malondialdehyde (MDA), a marker of oxidative stress in Beta Thalassemia major patients. (2019). International Journal of Biomedical and Advance Research, 10(12), e5182. https://ssjournals.co.in/index.php/ijbar/article/view/5182